Lucia Musacchio

Pubblicazioni

Titolo Pubblicato in Anno
The role of immunotherapy in advanced and recurrent MMR deficient and proficient endometrial carcinoma GYNECOLOGIC ONCOLOGY 2023
Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option? EXPERT OPINION ON DRUG SAFETY 2021
Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review ONCOLOGY 2020
Adnexal masses in pregnancy: an updated review on diagnosis and treatment TUMORI 2020
Immune checkpoint inhibitors: a promising choice for endometrial cancer patients? JOURNAL OF CLINICAL MEDICINE 2020
PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer VIRCHOWS ARCHIV 2020
Ovarian Cancer Metastasis to the Breast: A Case Report and Review of the Literature CASE REPORTS IN ONCOLOGY 2020
PARP inhibitors in endometrial cancer: Current status and perspectives CANCER MANAGEMENT AND RESEARCH 2020
Immunotherapy for ovarian cancer: recent advances and therapeutic combination approach ONCOTARGETS AND THERAPY 2020
Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients? GYNECOLOGIC ONCOLOGY 2019
Massive haemoperitoneum caused by uterine leiomyoma: a case report JOURNAL OF OBSTETRICS AND GYNAECOLOGY 2019
Obstetrical outcomes in women with history of breast cancer: a systematic review and meta-analysis BREAST CANCER RESEARCH AND TREATMENT 2019
Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer. EXPERT OPINION ON INVESTIGATIONAL DRUGS 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma